Does Ozempic cause high blood pressure? This is a common concern for patients prescribed semaglutide, particularly as many people with type 2 diabetes already have cardiovascular risk factors. Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for managing type 2 diabetes. Clinical evidence from large-scale trials, including the SUSTAIN programme, demonstrates that Ozempic does not typically cause high blood pressure. In fact, research suggests it may modestly reduce blood pressure in some patients, likely due to weight loss and improved metabolic health. Understanding how this medication affects cardiovascular parameters is essential for safe, effective diabetes management.

Understanding Ozempic and Its Effects on Blood Pressure

Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. It works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion in response to food intake, suppresses glucagon release, and slows gastric emptying. These mechanisms help improve glycaemic control and often lead to weight loss.

Many patients prescribed Ozempic have pre-existing cardiovascular risk factors, including hypertension (high blood pressure), as these conditions frequently coexist with type 2 diabetes. This raises an important question: does Ozempic itself cause high blood pressure, or does it affect blood pressure in other ways? Understanding the relationship between this medication and blood pressure is crucial for both patients and healthcare professionals managing long-term diabetes care.

The cardiovascular profile of GLP-1 receptor agonists has been extensively studied, particularly given that people with type 2 diabetes face elevated risks of heart disease and stroke. Clinical trials have examined whether semaglutide increases, decreases, or has a neutral effect on blood pressure. The evidence suggests that Ozempic does not typically cause high blood pressure; in fact, research indicates it may have modest beneficial effects on cardiovascular parameters, including blood pressure reduction in some patients.

It is important to note that individual responses to medication can vary. Whilst Ozempic is not recognised as a cause of hypertension, patients may experience changes in blood pressure during treatment for various reasons. Semaglutide can cause a small increase in resting heart rate, which some patients may experience as palpitations. If you notice persistent palpitations or a racing heartbeat, you should discuss this with your healthcare team.

Clinical Evidence: Does Ozempic Raise Blood Pressure?

Large-scale clinical trials provide reassuring evidence that Ozempic does not cause high blood pressure. The landmark SUSTAIN clinical trial programme, which evaluated semaglutide in thousands of patients with type 2 diabetes, consistently demonstrated either neutral or beneficial effects on blood pressure. In the SUSTAIN-6 cardiovascular outcomes trial, which included 3,297 participants, semaglutide was associated with modest reductions in systolic blood pressure compared to placebo.

Specifically, patients treated with semaglutide experienced average reductions in systolic blood pressure of approximately 2–5 mmHg across various studies. Whilst these reductions are modest, they are clinically meaningful when considered alongside the medication's other cardiovascular benefits. The MHRA (Medicines and Healthcare products Regulatory Agency) product information for Ozempic does not list hypertension as a recognised adverse effect, further supporting the conclusion that the medication does not cause elevated blood pressure.

Weight loss associated with Ozempic treatment likely contributes to blood pressure improvements observed in clinical trials. Many patients lose significant weight whilst taking semaglutide, and weight reduction is well-established as an effective non-pharmacological intervention for lowering blood pressure. Studies suggest that weight loss can contribute to blood pressure reduction, though the exact magnitude varies between individuals.

It is worth noting that individual patient experiences may differ from trial averages. Some patients report feeling their heart racing or experiencing palpitations when starting Ozempic. These symptoms may relate to the medication's effects on the gastrointestinal system, represent a physiological response to weight loss and metabolic changes, or reflect semaglutide's known small effect on increasing heart rate. If you experience persistent palpitations, you should seek medical advice. Based on current evidence, there is no official link between Ozempic and the development of high blood pressure.

Why Blood Pressure May Change During Ozempic Treatment

Several mechanisms may explain blood pressure changes observed in patients taking Ozempic, most of which are beneficial or neutral rather than harmful. The primary factor is weight loss, which occurs in a substantial proportion of patients treated with semaglutide. As body weight decreases, the cardiovascular system experiences reduced workload, and this often translates into lower blood pressure readings. Additionally, improvements in insulin sensitivity and glycaemic control may contribute to better vascular function.

GLP-1 receptors are present in various tissues beyond the pancreas, including the cardiovascular system. Activation of these receptors may have cardioprotective effects, including potentially improved endothelial function (the health of blood vessel linings) and reduced inflammation. These mechanisms could contribute to the blood pressure reductions observed in clinical studies, independent of weight loss effects.

Dehydration is an important consideration when discussing blood pressure changes during Ozempic treatment. The medication commonly causes gastrointestinal side effects, particularly nausea, vomiting, and diarrhoea, especially during the initial titration period. If these symptoms are severe, dehydration may occur, which typically lowers blood pressure and can cause dizziness, particularly when standing up. If you experience vomiting or diarrhoea and cannot keep fluids down, contact your healthcare provider promptly.

If you take medications for high blood pressure, diabetes, or kidney conditions, you may need to follow 'sick day rules' during episodes of vomiting or diarrhoea. This may involve temporarily stopping certain medicines such as ACE inhibitors, ARBs, diuretics, NSAIDs, metformin, or SGLT2 inhibitors until you can drink normally again. Always consult your healthcare team about specific guidance for your medications.

Some patients may experience changes in their antihypertensive medication requirements whilst taking Ozempic. If blood pressure decreases due to weight loss and improved metabolic health, existing blood pressure medications may need adjustment to prevent hypotension (excessively low blood pressure). Conversely, if a patient's blood pressure appears to rise, this may reflect inadequate control of their pre-existing hypertension rather than a direct effect of Ozempic.

Monitoring Blood Pressure While Taking Ozempic

Regular blood pressure monitoring is advisable for all patients with type 2 diabetes, regardless of whether they are taking Ozempic. NICE (National Institute for Health and Care Excellence) guidelines recommend that people with diabetes should have their blood pressure checked at least annually, and more frequently if they have diagnosed hypertension or are at high cardiovascular risk. When starting Ozempic, more frequent monitoring may be beneficial, particularly during the dose titration phase.

Patients who already take antihypertensive medications should be particularly attentive to blood pressure monitoring when commencing Ozempic. As weight loss occurs and metabolic parameters improve, blood pressure may decrease, potentially requiring adjustment of existing blood pressure medications. Signs of excessively low blood pressure include dizziness (particularly when standing), light-headedness, fatigue, and fainting. If these symptoms occur, patients should check their blood pressure and contact their GP or diabetes care team.

Home blood pressure monitoring can be a valuable tool for patients taking Ozempic. The NHS supports the use of validated home blood pressure monitors, which allow patients to track their readings between clinic appointments. When measuring blood pressure at home, follow the NICE-recommended protocol: rest for five minutes before measurement, sit with back supported and feet flat on the floor, and take two readings, one minute apart, morning and evening for 4-7 days. Discard the first day's readings and average the rest. The British and Irish Hypertension Society (BIHS) maintains a list of validated monitors suitable for home use.

If your clinic blood pressure reading is 140/90 mmHg or higher, your healthcare provider may recommend confirming this with ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM), where a diagnosis of hypertension would be confirmed with an average reading of 135/85 mmHg or higher.

For patients without pre-existing hypertension, routine monitoring during diabetes reviews is generally sufficient. However, if new symptoms develop—such as persistent headaches, visual changes, chest discomfort, or shortness of breath—blood pressure should be checked promptly. These symptoms may indicate various conditions, and whilst they are not typical side effects of Ozempic, they warrant medical evaluation to ensure appropriate diagnosis and management.

When to Seek Medical Advice About Blood Pressure Changes

Patients should contact their GP or diabetes care team if they experience significant changes in blood pressure whilst taking Ozempic. Specific situations requiring medical advice include: consistently elevated blood pressure readings above 140/90 mmHg (or above the individual target set by their healthcare team), symptoms suggesting low blood pressure such as recurrent dizziness or fainting, or any new cardiovascular symptoms including chest pain, palpitations, or unusual shortness of breath.

If blood pressure readings are consistently higher than usual, this warrants investigation even though Ozempic is not known to cause hypertension. Elevated readings may indicate that pre-existing hypertension requires better control, or they may reflect other factors such as medication non-adherence, dietary changes, increased stress, or the development of other medical conditions. A healthcare professional can assess the situation comprehensively and adjust treatment accordingly.

For people with diabetes, NICE recommends a blood pressure target of below 140/90 mmHg, or below 130/80 mmHg if you have kidney, eye, or cerebrovascular complications. Your healthcare team will advise on your individual target.

Conversely, symptoms of hypotension (low blood pressure) should also prompt medical review. These include feeling faint when standing up quickly (postural hypotension), persistent fatigue, confusion, or blurred vision. Patients taking multiple blood pressure medications alongside Ozempic may be at higher risk of hypotension, particularly if they experience significant weight loss. Medication adjustments may be necessary to maintain blood pressure within a healthy range.

Emergency medical attention is required if your blood pressure is very high (180/120 mmHg or higher) or if you have severe symptoms such as chest pain, severe headache with visual disturbance, difficulty breathing, or loss of consciousness. If you experience symptoms of stroke (follow the FAST guidance: Face weakness, Arm weakness, Speech problems, Time to call 999), seek emergency help immediately. Whilst these are not typical effects of Ozempic, they may indicate serious cardiovascular events requiring immediate assessment. Call 999 or attend A&E if such symptoms occur.

Finally, patients should maintain open communication with their healthcare team throughout Ozempic treatment. Regular diabetes reviews provide opportunities to discuss blood pressure trends, review home monitoring records, and adjust medications as needed. If you experience any suspected side effects from Ozempic, report these through the MHRA Yellow Card Scheme, which helps monitor medication safety. This collaborative approach ensures that both diabetes and blood pressure are optimally managed, maximising the cardiovascular benefits of treatment whilst minimising potential risks.

Frequently Asked Questions